Necmettin Erbakan University Meram Medical Faculty - Oncology

Konya 42080

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Melanoma

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now
• A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma — Running, not enrolling